期刊文献+

甲钴胺联合神经节苷脂治疗糖尿病周围神经病变的临床观察 被引量:7

下载PDF
导出
摘要 目的探讨甲钴胺联合神经节苷脂治疗糖尿病周围神经病变的临床疗效。方法对照组30例,常规糖尿病治疗加甲钴胺;治疗组30例在对照组基础上加神经节苷脂100 mg静滴。两组均治疗两周后判定疗效。结果总有效率对照组53.33%,治疗组90.0%,两组相比差异有显著统计学意义(P<0.01);正中神经、腓总神经的MNCV和SNCV的改善,治疗组优于对照组(P<0.05)。结论甲钴胺联合神经节苷脂治疗糖尿病周围神经病变有较大临床价值。
机构地区 解放军第
出处 《临床军医杂志》 CAS 2009年第4期709-711,共3页 Clinical Journal of Medical Officers
  • 相关文献

参考文献7

二级参考文献35

  • 1邵震宇,刘忆林,姜伟.单唾液酸四己糖神经节苷酯治疗帕金森病1例[J].医药导报,2004,23(9):657-657. 被引量:6
  • 2魏晓捷,付小君,许信龙.神经节苷脂治疗重型颅脑损伤的临床观察[J].浙江创伤外科,2001,6(1):19-19. 被引量:3
  • 3郑白蒂 胡国贤 等.糖尿病性神经病变治疗的探讨[J].中华内科杂志,1981,20(9):523-525.
  • 4[3]Karpiak SE, Li YS, Mahadik SP. Gangliosides (GML and AGF2)reduce mortality due to ischemia: protection of membrane function. Stroke, 1987,18( 1 ): 184
  • 5[4]Masserini M,Pito M,Ferrareto A, et al .Clycdipid- protein nteraction in the mechanism of signal transduction: studies with aphoto activable ganglioside analogue. Acts Biochem Pol, 1998,45(2 :393
  • 6[5]Sun FY, Faden AL. NMDA receptors mediate post transmitionincrease of protein kinase C in the brain. Brain Res, 1994,661:63
  • 7[6]Favaron M, Manev H, Alho H, et al. Gangliosides pervert glutamate and kainate neurotoxicity in primary neuronal culture of neonatal rat cerebelum and cortex. Proc Natl Acad Sci USA,1988,85(19) :7351
  • 8[7]Duchemin AM, Neff NH, Nadjiconstandno M. GM-1 increase the content and mRNA NGF in the brain of aged rats. Neuro Report,1997,8(17) :3823
  • 9Li YS,Mahadik SP,Rapport MM,et al.Acute effects of GM1 ganglioside:reduction in both behavioral asymmetry and loss of Na+,K+-ATPase after nigrostriatal transection.Brain Res,1986,377 (2):292-297.
  • 10Doherty P,Ashton SV,Skaper SD,et al.Ganglioside modulation of neural cell adhesion molecule and N-cadherin-dependent ncurite outgrowth.J Cell Biol,1992,117(5):1093-1099.

共引文献73

同被引文献57

引证文献7

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部